80
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles

, , , , , , ORCID Icon, , , & show all
Pages 5141-5146 | Published online: 29 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wei Pei, Sicheng Zhou, Jing Zhang, Haitao Zhou, Haipeng Chen, Jianjun Bi, Zhaoxu Zheng, Zheng Liu, Zheng Jiang, Zheng Wang, Qian Liu, Xishan Wang, Jianwei Liang & Qiang Feng. (2020) Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles. Cancer Management and Research 12, pages 12099-12110.
Read now

Articles from other publishers (10)

Maitreyi Patel, Amandeep Arora, Dipankar Mukherjee & Samrat Mukherjee. (2023) Effect of hyperthermic intraperitoneal chemotherapy on survival and recurrence rates in advanced gastric cancer: a systematic review and meta-analysis. International Journal of Surgery 109:8, pages 2435-2450.
Crossref
Zhiyuan Yu, Xudong Zhao, Shuzhong Qiu, Sixin Zhou, Peiyu Li & Na Liu. (2023) Hyperthermic Intraperitoneal Chemotherapy May Damage Renal Function and Cause Serum Electrolyte Disturbance: A Retrospective Observational Study. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 33:3, pages 302-309.
Crossref
Jing Zhang, Yuemin Sun, Xiaofeng Bai, Peng Wang, Liang Tian, Yantao Tian & Yuxin Zhong. (2023) Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles. Frontiers in Oncology 13.
Crossref
Haohao Lu, Chuansheng Zheng, Bin Liang & Bin Xiong. (2023) Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study. Anti-Cancer Agents in Medicinal Chemistry 23:4, pages 461-469.
Crossref
Chu Shen, Yao Lin, Xikai Guo, Yuan Li, Dianshi Wang, Zhouyuan Du, Peng Hu, Xin Chen, Xinyu Zeng, Jianbo Lv, Chuanqing Wu & Kaixiong Tao. (2022) Comparative Study of the Efficacy and Safety of Radical Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Gastric Cancer: A Propensity Score-Matching Analysis. Annals of Surgical Oncology 29:13, pages 8551-8563.
Crossref
Yunzi Wu, Xiaohao Zheng, Chunyang Sun, Shenghui Wang, Shikang Ding, Ming Wu, Jing Zhang, Bingzhi Wang, Liyan Xue, Lin Yang, Yantao Tian & Yibin Xie. (2022) Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis. BMC Surgery 22:1.
Crossref
Xingzhen Cheng, Fang Yang, Yang Wang, Wei Nie, Adarsha Mahendra Upadhyay, Maolin Zhang, Qian Wang & Zhiqiang Yan. (2022) Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-14.
Crossref
Jian-Feng Zhang, Ling Lv, Shuai Zhao, Qian Zhou & Cheng-Gang Jiang. (2022) Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages. Annals of Surgical Oncology 29:5, pages 3170-3186.
Crossref
Xuhui Zhuang, Yuewen He & Wuhua Ma. (2022) Prophylactic hyperthermic intraperitoneal chemotherapy may benefit the long-term survival of patients after radical gastric cancer surgery. Scientific Reports 12:1.
Crossref
Xuhui Zhuang, Yuewen He & Wuhua Ma. (2021) Is Prophylactic Hyperthermic Intraperitoneal Chemotherapy Beneficial to the Long-Term Survival of Patients After Radical Gastric Cancer Surgery: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref